基于常规MRI的软骨下骨小梁生物标志物预测膝骨关节炎进展:骨关节炎倡议数据
研究在骨关节炎倡议(OAI)中开发了常规中间加权MRI序列测量胫骨近端内侧软骨下骨小梁生物标志物的框架,评估其信度与效度,并分析基线至24个月生物标志物变化与膝骨关节炎疼痛及影像学进展的关联。结果显示cTbTh和cBV/TV信度可接受且与表观生物标志物及骨密度 modestly 相关,cTbTh增加与疼痛进展风险升高相关,cTbTh或cBV/TV降低与疼痛进展风险降低相关。
要点
- 常规中间加权MRI可定量测量软骨下骨小梁厚度、间距、连接密度及骨体积比等生物标志物。
- cTbTh和cBV/TV的信度可接受且与高分辨率MRI表观生物标志物及DXA骨密度呈 modest 关联。
- 基线至24个月cTbTh增加与48个月内膝骨关节炎疼痛进展风险升高相关(OR 1.44)。
核心结论
- 某些常规MRI测量的软骨下骨小梁生物标志物具有高信度和中等效度。
- 这些生物标志物变化与长达48个月随访的膝骨关节炎疼痛进展存在显著关联,尽管效应中等。
研究设计与样本
- 研究在骨关节炎倡议(OAI)框架内开发常规中间加权MRI序列测量胫骨近端内侧软骨下骨小梁生物标志物的方法。
- 在OAI的Bone Ancillary Study中评估测量信度,在FNIH OA Biomarkers Consortium中评估生物标志物变化与膝骨关节炎进展的关联。
- 效度通过与传统高分辨率稳态MRI序列获得的「表观」生物标志物及双能X线吸收法测量的关节周围骨密度比较来评估。
- 使用逻辑回归调整相关协变量分析基线至24个月生物标志物变化(基于可靠变化指数)与24至48个月疼痛及影像学进展的关联。
诊断标准与关键数值
- cTbTh与表观生物标志物及关节周围骨密度的关联β=1.10(95%CI 0.45-1.75),p=0.001。
- cBV/TV与表观生物标志物及关节周围骨密度的关联β=3.69(95%CI 2.56-4.83),p<0.001。
- cTbTh增加与膝骨关节炎疼痛进展的OR=1.44(95%CI 1.03-2.02),p=0.035。
- cTbTh降低与膝骨关节炎疼痛进展的OR=0.69(95%CI 0.49-0.95),p=0.026。
- cBV/TV降低与膝骨关节炎疼痛进展的OR=0.67(95%CI 0.48-0.93),p=0.018。
临床应用与阅片要点
- 常规中间加权MRI序列虽空间分辨率低于准确研究软骨下骨小梁微结构所需,但可能保留足够信息用于定量骨小梁微结构生物标志物。
- 从常规中间加权MRI获得的cTbTh、cTbSp和cBV/TV是骨小梁微结构变化的可靠且有效指标,与FISP MRI序列的表观生物标志物及DXA骨密度比较。
- 基线至24个月cTbTh和cBV/TV增加可能与48个月随访期内膝骨关节炎疼痛进展的更高风险相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the reliability and validity of measuring subchondral trabecular biomarkers in "conventional" intermediate-weighted (IW) MRI sequences and to assess the predictive value of biomarker changes for predicting near-term symptomatic and structural progressions in knee osteoarthritis (OA).
METHODS: For this study, a framework for measuring trabecular biomarkers in the proximal medial tibia in the "conventional" IW MRI sequence was developed. The reliability of measuring these biomarkers (trabecular thickness [cTbTh], spacing [cTbSp], connectivity density [cConnD], and bone-to-total volume ratio [cBV/TV]) was evaluated in the Bone Ancillary Study (within the Osteoarthritis Initiative [OAI]). The validity of these measurements was assessed by comparing to "apparent" biomarkers (from high-resolution steady-state MRI sequence) and peri-articular bone marrow density (BMD, from dual-energy X-ray absorptiometry). The association of these biomarker changes from baseline to 24 months (using the Reliable Change Index) with knee OA progression was studied in the FNIH OA Biomarkers Consortium (within the OAI). Pain and radiographic progression were evaluated by comparing baseline WOMAC pain score and radiographic joint space width with the 24-to-48-month scores/measurements. Associations between biomarker changes and these outcomes were studied using logistic regression adjusted for the relevant covariates.
RESULTS: With acceptable reliability, the cTbTh and cBV/TV, but not cTbSp or cConnD, were modestly associated with the "apparent" biomarkers and peri-articular BMD (β: 1.10 [95% CI: 0.45-1.75], p value: 0.001 and β: 3.69 [95% CI: 2.56-4.83], p value: < 0.001, respectively). Knees with increased cTbTh had higher (OR: 1.44 [95% CI: 1.03-2.02], p value: 0.035) and knees with decreased cTbTh (OR: 0.69 [95% CI: 0.49-0.95], p value: 0.026) or decreased cBV/TV (OR: 0.67 [95% CI: 0.48-0.93], p value: 0.018) had lower odds of experiencing OA pain progression over the follow-ups.
CONCLUSIONS: Measurement of certain "conventional" MRI-based subchondral trabecular biomarkers has high reliability and modest validity. Though modest, there are significant associations between these biomarker changes and knee OA pain progression up to 48-month follow-up.
KEY POINTS: • Despite the lower spatial resolution than what is required to accurately study the subchondral trabecular microstructures, the "conventional" IW MRI sequences may retain adequate information that allows quantification of trabecular microstructure biomarkers. • Subchondral trabecular biomarkers obtained from "conventional" IW MRI sequences (i.e., cTbTh, cTbSp, and cBV/TV) are reliable and valid measures of trabecular microstructure changes compared to those from "apparent" trabecular biomarkers (from the FISP MRI sequence) and peri-articular BMD (from DXA). • Increased trabecular thickness and bone-to-total ratio (cTbTh and cBV/TV, obtained from "conventional" IW MRI sequences) from baseline to 24-month visits may be associated with higher odds of knee OA pain progression over 48 months of follow-up.
引用
- Pishgar F, Guermazi A, Roemer FW, et al. Conventional MRI-based subchondral trabecular biomarkers as predictors of knee osteoarthritis progression: data from the Osteoarthritis Initiative. Eur Radiol. 2020. PMID: 33241511. doi:10.1007/s00330-020-07512-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。